Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

FAIRification – don’t overthink it, just do it and tell others how

Posted on March 4th, 2020 by

Pharma R&D

Ideas change the world, but rarely without a lot of missteps, rethinking and redoing. The FAIR Data Principles are no exception: mostly, they emerged from ideas that were developed over the course of years before being consolidated and named in 2016, and now we’re in the thick of trying, learning, maturing.

(more…)

Unlocking the potential of the Reaxys PhD prize – insights from 4 winners and finalists

Posted on March 2nd, 2020 by

Chemistry

The Reaxys PhD Prize, which honors young chemists for their innovative research, is now in its 10th year. It is a worldwide competition, open to those who are doing (or have recently completed) their PhD in any area of chemistry. Finalists each year automatically become a part of the Reaxys Prize Club, an exclusive international network of chemists from all research areas and career paths. Members of the club are also awarded with a broad range of benefits including free access to Reaxys, travel grants to network and explore research collaborations, and much more.

(more…)

Three drug development strategies to combat 2019 novel coronavirus

Posted on February 28th, 2020 by

COVID-19

Coronavirus disease 19 (COVID-19) has rapidly spread from its starting point in Wuhan, China. As of February 23, 2020, a total of 32 countries and territories have reported 78,811 cases (98% in China) and 2462 deaths [1]. The international scientific community is in a race against time. Researchers across the globe are collaborating to develop antivirals and vaccines to contain the spread of 2019 novel coronavirus (SARS-CoV-2).

(more…)

3 issues global pharmas should consider as the coronavirus outbreak continues

Posted on February 26th, 2020 by

COVID-19

It has been more than four weeks since the Wuhan lockdown on January 23. As the crisis unfolded, spring festival national holidays were extended (and extended again), and finally people are now gradually going back to work—though some cities, towns and villages are still taking strict measures to prevent the virus spreading further.

(more…)

Discover how drug repurposing is taking on rare disease

Posted on February 24th, 2020 by

Pharma R&D

This year, February 29 is Rare Disease Day, which is an annual event in which patient organizations around the world raise awareness of rare diseases through activities and special programming such as charity runs, documentary screenings, panel discussions, art contests and much more.

(more…)

Dedication to science drives a 20-year relationship between an information expert and a distinguished researcher

Posted on February 20th, 2020 by

Pharma R&D

With about 600 articles published in major dermatology journals, almost 40 books authored, 70 chapters in various books, and a h-index of 49, Dr. Robert Baran is one of the most knowledgeable dermatologists in the world. He began publishing more than 67 years ago, is invited to many international conferences every year, and his specialty is nails.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 72


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.